AdvanSix (ASIX) Q2 2026 earnings summary

Executive summary

• Sales grew 3% year-over-year to $421 million in Q2 2026, driven by favorable pricing but offset by lower volumes, especially in Plant Nutrients due to reduced grower demand and challenging farmer economics.

• Earnings per share fell sharply to $0.12 from $1.15 in Q2 2025; adjusted EPS was $0.19, down from $1.24.

• Cash flow from operations was $10 million, down 52% year-over-year, with free cash flow negative at $(10.7) million.

• Management focused on commercial execution, operational excellence, and disciplined capital deployment to drive value creation and shareholder returns.

• Resilience highlighted amid challenging macro conditions, particularly in agriculture and raw material markets.

Financial highlights

• Q2 2026 sales: $421.3 million (up 2.7%–3% year-over-year), driven by 18% favorable pricing but offset by a 15% volume decline.

• Adjusted EBITDA was $31.9 million (7.6% margin), down 43% from $55.7 million (13.6% margin) in Q2 2025.

• Net income dropped 90% year-over-year to $3.2 million.

• Adjusted EPS for Q2 2026: $0.19, down from $1.24 in Q2 2025.

• Capital expenditures decreased 27% to $20.7 million.

Outlook and guidance

• Sequential improvement in earnings and cash flow expected in 2H26, supported by reduced CapEx, working capital tailwinds, and cost reduction initiatives.

• Capital expenditures for 2026 guided at $75–$95 million, down from $116 million in 2025.

• Anticipate sulfur raw material price declines beginning in 4Q26, which should benefit earnings.

• Targeting $10 million in annual savings from fixed cost reduction program by end of 2026.

• Plan for 30% increase in ammonia sales volume in 2026 versus 2025.